Jellinger K, Radiaszkiewicz T
Virchows Arch A Pathol Anat Histol. 1976 Jul 21;370(4):345-62. doi: 10.1007/BF00445779.
A retrospective histologic study of 145 consecutive autopsy cases of systemic malignant lymphomas (including lymphatic leukemias) was performed. The classification followed the Kiel Classification (Gérard-Marchant et al., 1974). There was an overall secondary CNS involvement in 26.2% of the total or in 30.4% of the non-Hodgkin's lymphomas including ALL, with intracranial lesions in 21.4 and 26.1%, respectively, and spinal epidural spread in 5.5 (5.1%). Peripheral nerve involvement was seen in almost 40% of the examined cases. Ten further cases were isolated ("primary") intracranial lymphomas without evidence of extraneural deposits or systemic lymphatic disease. The CNS complications in non-Hodgkin's lymphomas were diffuse meningeal and/or perivascular infiltration with or without invasion of the nervous parenchyma, and did not differ from those in CNS leukemia. Isolated solid mass lesions in the brain were only present in 7% of the secondary CNS lymphomas, but were seen in all instances of "primary" cerebral lymphomas. The incidence of CNS complications was highest in lymphoblastic lymphomas including ALL (39%), CLL (31%), immunocytic lymphoma (29%), less frequent in immunoblastic (18.7%), and centrocytic lymphomas (16.6%). No intracranial lesion was observed in centroblastic-centrocytic and centroblastic lymphomas which only produced epidural spread. Bone marrow involvement was present in 92.8% of the cases with secondary CNS lesions, and in 83.2% of the epidural lymphomas. Leukemic conversion, present in 44% of the total (52% with ALL), was demonstrated in 83.3% of the cases with secondary brain lesions, but was hardly combined with epidural spread. The histologic pattern of CNS lesions in non-Hodgkin's lymphomas and their frequent association with leukemic conversion suggest the importance of hematogenous dissemination rather than of direct spread from bone marrow or local manifestation in multisystem disease. Isolated ("primary") lymphomas of the CNS which are morphologically identical with the extraneural lymphomas may represent a primary, often lethal manifestation of a multisystem disease with or without secondary generalization.
对145例连续性系统性恶性淋巴瘤(包括淋巴白血病)尸检病例进行了回顾性组织学研究。分类采用基尔分类法(热拉尔 - 马尔尚等人,1974年)。在全部病例中,中枢神经系统继发性受累占26.2%,在包括急性淋巴细胞白血病(ALL)的非霍奇金淋巴瘤中占30.4%,其中颅内病变分别占21.4%和26.1%,脊髓硬膜外扩散占5.5%(5.1%)。在近40%的检查病例中可见周围神经受累。另有10例为孤立性(“原发性”)颅内淋巴瘤,无神经外沉积物或系统性淋巴疾病证据。非霍奇金淋巴瘤的中枢神经系统并发症为弥漫性脑膜和/或血管周围浸润,伴或不伴有神经实质侵犯,与中枢神经系统白血病的并发症无差异。继发性中枢神经系统淋巴瘤中仅7%出现脑内孤立性实性肿块病变,但在所有“原发性”脑淋巴瘤病例中均可见。中枢神经系统并发症发生率在包括ALL的淋巴母细胞淋巴瘤中最高(39%),慢性淋巴细胞白血病(CLL)中为31%,免疫细胞淋巴瘤中为29%,在免疫母细胞淋巴瘤(18.7%)和中心细胞淋巴瘤(16.6%)中较低。中心母细胞 - 中心细胞淋巴瘤和中心母细胞淋巴瘤仅出现硬膜外扩散,未观察到颅内病变。继发性中枢神经系统病变病例中92.8%存在骨髓受累,硬膜外淋巴瘤病例中83.2%存在骨髓受累。白血病转化在全部病例中占44%(ALL病例中占52%),在继发性脑病变病例中83.3%出现,但很少与硬膜外扩散同时存在。非霍奇金淋巴瘤中枢神经系统病变的组织学模式及其与白血病转化的频繁关联提示血行播散的重要性,而非骨髓直接扩散或多系统疾病的局部表现。形态学上与神经外淋巴瘤相同的孤立性(“原发性”)中枢神经系统淋巴瘤可能代表多系统疾病的原发性、通常致命的表现,伴或不伴有继发性播散。